TADEROS Trademark

Trademark Overview


On Monday, January 16, 2017, a trademark application was filed for TADEROS with the United States Patent and Trademark Office. The USPTO has given the TADEROS trademark a serial number of 87303154. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 17, 2018. This trademark is owned by Glaxo Group Limited. The TADEROS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
taderos

General Information


Serial Number87303154
Word MarkTADEROS
Filing DateMonday, January 16, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 17, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, December 17, 2018ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 17, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 2 GRANTED
Monday, May 7, 2018EXTENSION 2 FILED
Monday, May 7, 2018TEAS EXTENSION RECEIVED
Thursday, November 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2017EXTENSION 1 GRANTED
Tuesday, November 14, 2017EXTENSION 1 FILED
Tuesday, November 14, 2017TEAS EXTENSION RECEIVED
Tuesday, May 16, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 30, 2017ASSIGNED TO EXAMINER
Tuesday, January 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 19, 2017NEW APPLICATION ENTERED IN TRAM